These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

197 related items for PubMed ID: 16288366

  • 21. International workshop on erythema nodosum leprosum (ENL)--consensus report; the formation of ENLIST, the ENL international study group.
    Walker SL, Saunderson P, Kahawita IP, Lockwood DN.
    Lepr Rev; 2012 Dec; 83(4):396-407. PubMed ID: 23614260
    [No Abstract] [Full Text] [Related]

  • 22. Erythema Nodosum Leprosum Neutrophil Subset Expressing IL-10R1 Transmigrates into Skin Lesions and Responds to IL-10.
    Pacheco FS, Prata RBDS, Brandão SS, Ferreira H, Rodrigues TF, Brandão Dos Santos J, da Silva CO, Tavares IF, Mendes MA, Rodrigues ACDP, Machado AM, Nery JADC, Amadeu TP, Moraes MO, Sarno EN, Schmitz V.
    Immunohorizons; 2020 Feb 07; 4(2):47-56. PubMed ID: 32034084
    [Abstract] [Full Text] [Related]

  • 23. Rare atypical presentations in Type 2 lepra reaction: a case series.
    Vijendran P, Verma R, Vasudevan B, Mitra D, Badad A, Neema S.
    Int J Dermatol; 2014 Mar 07; 53(3):323-6. PubMed ID: 24134145
    [Abstract] [Full Text] [Related]

  • 24. Severe form of type 2 reaction in patients of Hansen's disease after withdrawal of thalidomide: case reports.
    Rattan R, Shanker V, Tegta GR, Verma GK.
    Indian J Lepr; 2009 Mar 07; 81(4):199-203. PubMed ID: 20704076
    [Abstract] [Full Text] [Related]

  • 25. Role of azathioprine in preventing recurrences in a patient of recurrent erythema nodosum leprosum.
    Verma KK, Srivastava P, Minz A, Verma K.
    Lepr Rev; 2006 Sep 07; 77(3):225-9. PubMed ID: 17172003
    [Abstract] [Full Text] [Related]

  • 26. Deep vein thrombosis: a rare complication of thalidomide therapy in recurrent erythema nodosum leprosum.
    Sharma NL, Sharma V, Shanker V, Mahajan VK, Sarin S.
    Int J Lepr Other Mycobact Dis; 2004 Dec 07; 72(4):483-5. PubMed ID: 15755204
    [Abstract] [Full Text] [Related]

  • 27. Recognizing and managing the immunologic reactions in leprosy.
    Kamath S, Vaccaro SA, Rea TH, Ochoa MT.
    J Am Acad Dermatol; 2014 Oct 07; 71(4):795-803. PubMed ID: 24767732
    [Abstract] [Full Text] [Related]

  • 28. Prolonged treatment with recombinant interferon gamma induces erythema nodosum leprosum in lepromatous leprosy patients.
    Sampaio EP, Moreira AL, Sarno EN, Malta AM, Kaplan G.
    J Exp Med; 1992 Jun 01; 175(6):1729-37. PubMed ID: 1588290
    [Abstract] [Full Text] [Related]

  • 29. Canadian case report of erythema nodosum leprosum successfully treated with prednisone and thalidomide.
    Saber M, Bourassa-Fulop C, Bouffard D, Provost N.
    J Cutan Med Surg; 2010 Jun 01; 14(2):95-9. PubMed ID: 20338126
    [Abstract] [Full Text] [Related]

  • 30. Sequential erythema nodosum leprosum and reversal reaction with similar lesional cytokine mRNA patterns in a borderline leprosy patient.
    Moraes MO, Sampaio EP, Nery JA, Saraiva BC, Alvarenga FB, Sarno EN.
    Br J Dermatol; 2001 Jan 01; 144(1):175-81. PubMed ID: 11167702
    [Abstract] [Full Text] [Related]

  • 31. Erythema nodosum leprosum in Nepal: a retrospective study of clinical features and response to treatment with prednisolone or thalidomide.
    Feuth M, Brandsma JW, Faber WR, Bhattarai B, Feuth T, Anderson AM.
    Lepr Rev; 2008 Sep 01; 79(3):254-69. PubMed ID: 19009975
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Interventions for erythema nodosum leprosum.
    Van Veen NH, Lockwood DN, van Brakel WH, Ramirez J, Richardus JH.
    Cochrane Database Syst Rev; 2009 Jul 08; 2009(3):CD006949. PubMed ID: 19588412
    [Abstract] [Full Text] [Related]

  • 34. Pentoxifylline decreases in vivo and in vitro tumour necrosis factor-alpha (TNF-alpha) production in lepromatous leprosy patients with erythema nodosum leprosum (ENL).
    Sampaio EP, Moraes MO, Nery JA, Santos AR, Matos HC, Sarno EN.
    Clin Exp Immunol; 1998 Feb 08; 111(2):300-8. PubMed ID: 9486396
    [Abstract] [Full Text] [Related]

  • 35. Evaluation of the influence of genetic variants in Cereblon gene on the response to the treatment of erythema nodosum leprosum with thalidomide.
    Costa PDSS, Maciel-Fiuza MF, Kowalski TW, Fraga LR, Feira MF, Camargo LMA, Caldoncelli DIO, Silveira MIDS, Schuler-Faccini L, Vianna FSL.
    Mem Inst Oswaldo Cruz; 2022 Feb 08; 117():e220039. PubMed ID: 36383784
    [Abstract] [Full Text] [Related]

  • 36. IgG antibody subclasses, tumor necrosis factor and IFN-gamma levels in patients with type II lepra reaction on thalidomide treatment.
    Partida-Sanchez S, Favila-Castillo L, Pedraza-Sanchez S, Gomez-Melgar M, Saul A, Estrada-Parra S, Estrada-Garcia I.
    Int Arch Allergy Immunol; 1998 May 08; 116(1):60-6. PubMed ID: 9623511
    [Abstract] [Full Text] [Related]

  • 37. Elevated Pentraxin-3 Concentrations in Patients With Leprosy: Potential Biomarker of Erythema Nodosum Leprosum.
    Mendes MA, de Carvalho DS, Amadeu TP, Silva BJA, Prata RBDS, da Silva CO, Ferreira H, Hacker MA, Nery JAC, Pinheiro RO, Sampaio EP, Sarno EN, Schmitz V.
    J Infect Dis; 2017 Dec 19; 216(12):1635-1643. PubMed ID: 29272525
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Thalidomide in erythema nodosum leprosum (ENL).
    Bourdillon C.
    Lepr Rev; 1988 Jun 19; 59(2):184-5. PubMed ID: 3246930
    [No Abstract] [Full Text] [Related]

  • 40. [Japanese guideline on thalidomide usage in the management of erythema nodosum leprosum].
    Ishii N, Ishida Y, Okano Y, Ozaki M, Gidoh M, Kumano K, Goto M, Nogami R, Hatano K, Yamada A, Yotsu RR.
    Nihon Hansenbyo Gakkai Zasshi; 2011 Sep 19; 80(3):275-85. PubMed ID: 21941834
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 10.